- Total raised
- $379.5M
- Stage
- Public
- Team size
- 51-200 employees
- Founded
- 2016
- HQ
- Lexington
About Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Open roles · 2
Location
More startups in Lexington
VulnCheck
Lexington
VulnCheck provides vulnerability intelligence and exploit monitoring services for security teams.
Rapid Micro Biosystems
Lexington
Rapid Micro Biosystems is the leader in automated microbial contamination detection for pharmaceutical manufacturing
Genezen
Lexington
Bringing Therapies to Life
Space Tango
Lexington
Space Tango designs and builds hardware and software platforms that enable microgravity research.
MEDICILON USA
Lexington
Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China
MiNK Therapeutics
Lexington
MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.